Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2017-03-14 | 2017-03-14 |
| Drug Identification Number | 02249669 | 02249669 |
| Brand name | PAMIDRONATE DISODIUM OMEGA 3 MG/ML | PAMIDRONATE DISODIUM OMEGA 3 MG/ML |
| Common or Proper name | Pamidrontae Disodium for Injection 30mg/10mL | Pamidrontae Disodium for Injection 30mg/10mL |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | PAMIDRONATE DISODIUM | PAMIDRONATE DISODIUM |
| Strength(s) | 3.0MG | 3.0MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 10mL vial | 10mL vial |
| ATC code | M05BA | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2013-01-01 | 2013-01-01 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | 6mg/mL and 9mg/mL formats remain available. | 6mg/mL and 9mg/mL formats remain available. |
| Health Canada comments |